Unique Wealth LLC Invests $330,000 in Genpact Limited (NYSE:G)

Unique Wealth LLC acquired a new stake in Genpact Limited (NYSE:G - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 6,556 shares of the business services provider's stock, valued at approximately $330,000.

Other hedge funds have also recently modified their holdings of the company. State of New Jersey Common Pension Fund D purchased a new stake in shares of Genpact during the fourth quarter worth about $2,030,000. Pictet Asset Management Holding SA purchased a new stake in shares of Genpact during the fourth quarter worth $921,000. Proficio Capital Partners LLC purchased a new stake in shares of Genpact during the fourth quarter worth $983,000. Cetera Investment Advisers lifted its stake in Genpact by 4.7% in the 4th quarter. Cetera Investment Advisers now owns 13,269 shares of the business services provider's stock worth $570,000 after purchasing an additional 595 shares in the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares during the period. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Stock Down 1.3%

Shares of G opened at $42.08 on Friday. The company's 50-day simple moving average is $46.13 and its 200-day simple moving average is $47.22. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a 1 year low of $30.38 and a 1 year high of $56.76. The stock has a market capitalization of $7.36 billion, a PE ratio of 14.82, a P/E/G ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The company had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. During the same quarter last year, the company posted $0.73 EPS. The firm's revenue was up 7.4% compared to the same quarter last year. Analysts forecast that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This represents a 4.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, with a total value of $87,940.00. Following the purchase, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. This represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research firms have issued reports on G. Mizuho raised their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Robert W. Baird reduced their price objective on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Needham & Company LLC decreased their price objective on shares of Genpact from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, Genpact has an average rating of "Hold" and a consensus target price of $50.71.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.